Cure Pharmaceutical Holding Corp. Revenue 2023–2024
Cure Pharmaceutical Holding Corp. annual/quarterly revenue history and growth rate from 2023 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cure Pharmaceutical Holding Corp. revenue for the quarter ending March 31, 2025 was 10.1 M, a 23.26% decrease year-over-year.
- Cure Pharmaceutical Holding Corp. revenue for the twelve months ending March 31, 2025 was 47.2 M.
- Cure Pharmaceutical Holding Corp. annual revenue for 2024 was 46.4 M, a 12.81% decrease from 2023.
- Cure Pharmaceutical Holding Corp. annual revenue for 2023 was 53.3 M.
Cure Pharmaceutical Holding Corp. (CURR) — Frequently Asked Questions
Cure Pharmaceutical Holding Corp. (CURR) is a publicly traded US company. It has a market capitalization of $113M. In fiscal 2024 it reported revenue of $46M and net income of -$39M. Explore CURR's stock price, financial statements, earnings history, margins and key ratios below.
What is Cure Pharmaceutical Holding Corp.'s market cap?
Cure Pharmaceutical Holding Corp. (CURR) has a market capitalization of $113M.
What is the CURR stock price?
CURR trades at $2.95 (+0.68% on the day).
How much revenue does Cure Pharmaceutical Holding Corp. make?
Cure Pharmaceutical Holding Corp. reported revenue of $46M in fiscal 2024.
Is CURR profitable?
In fiscal 2024, Cure Pharmaceutical Holding Corp. reported net income of -$39M.